IL17A and psoriasis: Differentiated KCs have been suggested to be the primary responders to IL-17A in psoriasis on the basis of previous studies by using in vitro KC systems, given larger effect sizes in differentiated compared with monolayer KCs (Chiricozzi et al., 2014).